Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Targeted suppression of CCR7/NF-κB signaling by apoptotic body-inspired colchicine nanovesicles halts atherosclerotic progression
by
Zhang, Yu-Bo
, Zhang, Huan-Tian
, Hu, Liu-Bing
, Chen, Qi
, Zhang, Guan-Yan
, Dong, Pei-Na
, Peng, Yuan-Shu
, Shen, Si
, Wang, Zhi-Guo
, Xu, Yi-Xian
, Zhong, Qian
, Zeng, Rong
, Wang, Jing-Hao
, Wang, Hao
in
Animal models
/ Animals
/ Anti-Inflammatory Agents - pharmacology
/ Apolipoprotein E
/ Apoptosis
/ Apoptosis - drug effects
/ Apoptotic cell-derived microvesicles
/ Arteriosclerosis
/ Atherosclerosis
/ Atherosclerosis - drug therapy
/ Atherosclerosis - metabolism
/ Atherosclerosis - pathology
/ Biodistribution
/ Biotechnology
/ CC chemokine receptors
/ Cell activation
/ Chemistry
/ Chemistry and Materials Science
/ Chronic inflammation
/ Colchicine
/ Colchicine - chemistry
/ Colchicine - pharmacology
/ Cytokines
/ Cytotoxicity
/ Disease
/ Disease Progression
/ Flow cytometry
/ Foam Cells - drug effects
/ Foam Cells - metabolism
/ Humans
/ Immunomodulation
/ Inflammation
/ Inflammatory diseases
/ Macrophages
/ Male
/ Mice
/ Mice, Inbred C57BL
/ Microscopy
/ Molecular Medicine
/ Nanoparticles
/ Nanotechnology
/ NF-kappa B - metabolism
/ NF-κB protein
/ Particle size
/ Phagocytes
/ Phosphatidylserine
/ Phosphatidylserines - chemistry
/ Receptors, CCR7 - metabolism
/ Signal transduction
/ Signal Transduction - drug effects
/ Toxicity
2025
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Targeted suppression of CCR7/NF-κB signaling by apoptotic body-inspired colchicine nanovesicles halts atherosclerotic progression
by
Zhang, Yu-Bo
, Zhang, Huan-Tian
, Hu, Liu-Bing
, Chen, Qi
, Zhang, Guan-Yan
, Dong, Pei-Na
, Peng, Yuan-Shu
, Shen, Si
, Wang, Zhi-Guo
, Xu, Yi-Xian
, Zhong, Qian
, Zeng, Rong
, Wang, Jing-Hao
, Wang, Hao
in
Animal models
/ Animals
/ Anti-Inflammatory Agents - pharmacology
/ Apolipoprotein E
/ Apoptosis
/ Apoptosis - drug effects
/ Apoptotic cell-derived microvesicles
/ Arteriosclerosis
/ Atherosclerosis
/ Atherosclerosis - drug therapy
/ Atherosclerosis - metabolism
/ Atherosclerosis - pathology
/ Biodistribution
/ Biotechnology
/ CC chemokine receptors
/ Cell activation
/ Chemistry
/ Chemistry and Materials Science
/ Chronic inflammation
/ Colchicine
/ Colchicine - chemistry
/ Colchicine - pharmacology
/ Cytokines
/ Cytotoxicity
/ Disease
/ Disease Progression
/ Flow cytometry
/ Foam Cells - drug effects
/ Foam Cells - metabolism
/ Humans
/ Immunomodulation
/ Inflammation
/ Inflammatory diseases
/ Macrophages
/ Male
/ Mice
/ Mice, Inbred C57BL
/ Microscopy
/ Molecular Medicine
/ Nanoparticles
/ Nanotechnology
/ NF-kappa B - metabolism
/ NF-κB protein
/ Particle size
/ Phagocytes
/ Phosphatidylserine
/ Phosphatidylserines - chemistry
/ Receptors, CCR7 - metabolism
/ Signal transduction
/ Signal Transduction - drug effects
/ Toxicity
2025
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Targeted suppression of CCR7/NF-κB signaling by apoptotic body-inspired colchicine nanovesicles halts atherosclerotic progression
by
Zhang, Yu-Bo
, Zhang, Huan-Tian
, Hu, Liu-Bing
, Chen, Qi
, Zhang, Guan-Yan
, Dong, Pei-Na
, Peng, Yuan-Shu
, Shen, Si
, Wang, Zhi-Guo
, Xu, Yi-Xian
, Zhong, Qian
, Zeng, Rong
, Wang, Jing-Hao
, Wang, Hao
in
Animal models
/ Animals
/ Anti-Inflammatory Agents - pharmacology
/ Apolipoprotein E
/ Apoptosis
/ Apoptosis - drug effects
/ Apoptotic cell-derived microvesicles
/ Arteriosclerosis
/ Atherosclerosis
/ Atherosclerosis - drug therapy
/ Atherosclerosis - metabolism
/ Atherosclerosis - pathology
/ Biodistribution
/ Biotechnology
/ CC chemokine receptors
/ Cell activation
/ Chemistry
/ Chemistry and Materials Science
/ Chronic inflammation
/ Colchicine
/ Colchicine - chemistry
/ Colchicine - pharmacology
/ Cytokines
/ Cytotoxicity
/ Disease
/ Disease Progression
/ Flow cytometry
/ Foam Cells - drug effects
/ Foam Cells - metabolism
/ Humans
/ Immunomodulation
/ Inflammation
/ Inflammatory diseases
/ Macrophages
/ Male
/ Mice
/ Mice, Inbred C57BL
/ Microscopy
/ Molecular Medicine
/ Nanoparticles
/ Nanotechnology
/ NF-kappa B - metabolism
/ NF-κB protein
/ Particle size
/ Phagocytes
/ Phosphatidylserine
/ Phosphatidylserines - chemistry
/ Receptors, CCR7 - metabolism
/ Signal transduction
/ Signal Transduction - drug effects
/ Toxicity
2025
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Targeted suppression of CCR7/NF-κB signaling by apoptotic body-inspired colchicine nanovesicles halts atherosclerotic progression
Journal Article
Targeted suppression of CCR7/NF-κB signaling by apoptotic body-inspired colchicine nanovesicles halts atherosclerotic progression
2025
Request Book From Autostore
and Choose the Collection Method
Overview
Atherosclerosis (AS) is a chronic inflammatory disorder characterized by foam cell formation and persistent inflammation as central pathological drivers. Although colchicine (Col) exhibits potent anti-inflammatory activities, its clinical application is limited by a narrow therapeutic window. In the present study, we developed phosphatidylserine-exposing nanovesicles (Col@PSVs) that leverage the innate phagocytic capacity of macrophage-derived foam cells by presenting surface “eat-me” signals, thereby enabling targeted immune modulation. The synergistic collaboration between Col and PSVs allows low-dose Col to retain robust anti-inflammatory efficacy while mitigating dose-dependent toxicity. Mechanistically, Col@PSVs potently suppress CCR7-mediated NF-κB signaling activation in foam cells, leading to a marked downregulation of pro-inflammatory cytokine and disruption of inflammatory cascades. In
ApoE
−/−
AS mouse models, Col@PSVs treatment significantly improved plaque stability and attenuated disease progression. These findings highlight the pivotal role of the CCR7/NF-κB signaling pathway in AS-associated inflammation and present a translational nanotherapeutic strategy with the potential to overcome the clinical limitations of Col.
Graphical Abstract
Publisher
BioMed Central,Springer Nature B.V,BMC
Subject
/ Animals
/ Anti-Inflammatory Agents - pharmacology
/ Apoptotic cell-derived microvesicles
/ Atherosclerosis - drug therapy
/ Atherosclerosis - metabolism
/ Chemistry and Materials Science
/ Disease
/ Humans
/ Male
/ Mice
/ Phosphatidylserines - chemistry
/ Receptors, CCR7 - metabolism
/ Signal Transduction - drug effects
/ Toxicity
MBRLCatalogueRelatedBooks
Related Items
Related Items
This website uses cookies to ensure you get the best experience on our website.